Tradestie Institutional Equity Comparison Engine
ABVEW vs CDT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABVEW Overall Edge
ABVEW Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Above Food Ingredients Inc. Warrants (ABVEW) driven by superior Momentum & Technical, Options & Structure while CDT counters with relative strength in Growth & Margin. Fundamentally, ABVEW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CDT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ABVEW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ABVEW N/M vs CDT N/M Fwd P/E
Growth & Margin Winner
CDT
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
ABVEW
1Y -64.7% vs -86.8% ยท 52W Pos 0% vs 2%
Options & Structure Winner
ABVEW
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
ABVEW
NASDAQ
Above Food Ingredients Inc. Warrants
Institutional Equity
$0.02
-86.37% 1D
Market Cap
N/A
1M Return
-87.14%
1Y Return
-64.71%
Forward P/E
N/M
Unified AI Score
37.2 / 100
SELL
Tech 25.0
Fund 42.0
Flow 50.0
Mom 53.0
CDT
NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap
$507,528
1M Return
+76.79%
1Y Return
-86.78%
Forward P/E
N/M
Unified AI Score
31.6 / 100
SELL
Tech 15.0
Fund 37.0
Flow 50.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ABVEW -64.71%
CDT -86.78%
Spread: +48.39 pp (CDT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ABVEW TTM Op. Margin: N/A
CDT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVEW vs CDT. Trailing 12-month operating profitability (ABVEW N/A vs CDT 0.0%) and valuation multiples (ABVEW N/M vs CDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABVEW | CDT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $507,528 | Larger Scale | CDT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | CDT |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | CDT |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | CDT |
| Return on Equity (ROE) Capital Efficiency | N/A | -69.7% | Higher ROE | CDT |
| 52-Week Range Position Momentum | 0% ($0โ$2) | 2% ($0โ$11) | Stronger Trend | CDT |
| Beta / 30D Volatility Risk Regime | 4.07ฮฒ ยท 408% Vol | -17.75ฮฒ ยท 10175% Vol | Lower Realized Risk | ABVEW |
| Unified Institutional Score Composite Signal | 37.2 / 100 (SELL) | 31.6 / 100 (SELL) | Higher Composite | ABVEW |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ABVEW vs CDT Buy Guide
ABVEW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CDT
BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ABVEW nor CDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.